These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 34195490)

  • 41. Detailed evaluation of an automated approach to interactive optimization for volumetric modulated arc therapy plans.
    Tol JP; Dahele M; Delaney AR; Doornaert P; Slotman BJ; Verbakel WF
    Med Phys; 2016 Apr; 43(4):1818. PubMed ID: 27036579
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evidence-Based Planning Target Volume Margin Reduction for Modern Lung Stereotactic Ablative Radiation Therapy Using Deformable Registration.
    Jasper K; Liu B; Olson R; Matthews Q
    Adv Radiat Oncol; 2021; 6(6):100750. PubMed ID: 34401609
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Persistently better treatment planning results of intensity-modulated (IMRT) over conformal radiotherapy (3D-CRT) in prostate cancer patients with significant variation of clinical target volume and/or organs-at-risk.
    Fenoglietto P; Laliberte B; Allaw A; Ailleres N; Idri K; Hay MH; Moscardo CL; Gourgou S; Dubois JB; Azria D
    Radiother Oncol; 2008 Jul; 88(1):77-87. PubMed ID: 18215434
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adaptive liver stereotactic body radiation therapy: automated daily plan reoptimization prevents dose delivery degradation caused by anatomy deformations.
    Leinders SM; Breedveld S; Méndez Romero A; Schaart D; Seppenwoolde Y; Heijmen BJ
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1016-21. PubMed ID: 24071500
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Stereotactic MR-guided adaptive radiation therapy for peripheral lung tumors.
    Finazzi T; Palacios MA; Haasbeek CJA; Admiraal MA; Spoelstra FOB; Bruynzeel AME; Slotman BJ; Lagerwaard FJ; Senan S
    Radiother Oncol; 2020 Mar; 144():46-52. PubMed ID: 31710943
    [TBL] [Abstract][Full Text] [Related]  

  • 46. To gate or not to gate - dosimetric evaluation comparing Gated vs. ITV-based methodologies in stereotactic ablative body radiotherapy (SABR) treatment of lung cancer.
    Kim J; Wu Q; Zhao B; Wen N; Ajlouni M; Movsas B; Chetty IJ
    Radiat Oncol; 2016 Sep; 11(1):125. PubMed ID: 27659780
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of magnetic resonance-guided versus conventional radiotherapy workflows on organ at risk doses in stereotactic body radiotherapy for lymph node oligometastases.
    Werensteijn-Honingh AM; Kroon PS; Winkel D; van Gaal JC; Hes J; Snoeren LMW; Timmer JK; Mout CCP; Bol GH; Kotte AN; Eppinga WSC; Intven M; Raaymakers BW; Jürgenliemk-Schulz IM
    Phys Imaging Radiat Oncol; 2022 Jul; 23():66-73. PubMed ID: 35814260
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assessment of online adaptive MR-guided stereotactic body radiotherapy of liver cancers.
    Padgett KR; Simpson G; Asher D; Portelance L; Bossart E; Dogan N
    Phys Med; 2020 Sep; 77():54-63. PubMed ID: 32781388
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Improved Ipsilateral Breast and Chest Wall Sparing With MR-Guided 3-fraction Accelerated Partial Breast Irradiation: A Dosimetric Study Comparing MR-Linac and CT-Linac Plans.
    Musunuru HB; Yadav P; Olson SJ; Anderson BM
    Adv Radiat Oncol; 2021; 6(3):100654. PubMed ID: 34195491
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Determining Planning Priorities for SABR for Oligometastatic Disease: A Secondary Analysis of the SABR-COMET Phase II Randomized Trial.
    Van Oirschot M; Bergman A; Verbakel WFAR; Ward L; Gagne I; Huang V; Chng N; Houston P; Symes K; Thomas CG; Basran P; Bowes D; Harrow S; Olson R; Senan S; Warner A; Palma DA; Gaede S
    Int J Radiat Oncol Biol Phys; 2022 Dec; 114(5):1016-1021. PubMed ID: 35031340
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dosimetric comparison of brachyablation and stereotactic ablative body radiotherapy in the treatment of liver metastasis.
    Pennington JD; Park SJ; Abgaryan N; Banerjee R; Lee PP; Loh C; Lee E; Demanes DJ; Kamrava M
    Brachytherapy; 2015; 14(4):537-42. PubMed ID: 25944395
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Volumetric-modulated arc therapy vs. c-IMRT in esophageal cancer: a treatment planning comparison.
    Yin L; Wu H; Gong J; Geng JH; Jiang F; Shi AH; Yu R; Li YH; Han SK; Xu B; Zhu GY
    World J Gastroenterol; 2012 Oct; 18(37):5266-75. PubMed ID: 23066322
    [TBL] [Abstract][Full Text] [Related]  

  • 53. SU-D-211-03: An Automated Inverse Planning Optimization Approach for Single- Fraction and Fractionated Radiosurgery Using Gamma Knife Perfexion.
    Ghobadi K; Ghaffari H; Aleman D; Ruschin M; Jaffray D
    Med Phys; 2012 Jun; 39(6Part3):3610. PubMed ID: 28517428
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dosimetric Benefit of Adaptive Magnetic Resonance-Guided Stereotactic Body Radiotherapy of Liver Metastases.
    Weykamp F; Katsigiannopulos E; Piskorski L; Regnery S; Hoegen P; Ristau J; Renkamp CK; Liermann J; Forster T; Lang K; König L; Rippke C; Buchele C; Debus J; Klüter S; Hörner-Rieber J
    Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551527
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Retrospective study comparing MR-guided radiation therapy (MRgRT) setup strategies for prostate treatment: repositioning vs. replanning.
    Kim JI; Park JM; Choi CH; An HJ; Kim YJ; Kim JH
    Radiat Oncol; 2019 Aug; 14(1):139. PubMed ID: 31387593
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dose-shaping using targeted sparse optimization.
    Sayre GA; Ruan D
    Med Phys; 2013 Jul; 40(7):071711. PubMed ID: 23822415
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A patient-specific planning target volume used in 'plan of the day' adaptation for interfractional motion mitigation.
    Chen W; Gemmel A; Rietzel E
    J Radiat Res; 2013 Jul; 54 Suppl 1(Suppl 1):i82-90. PubMed ID: 23824132
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
    Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
    J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of dose calculation accuracy during optimization on lung IMRT plan quality.
    Li Y; Rodrigues A; Li T; Yuan L; Yin FF; Wu QJ
    J Appl Clin Med Phys; 2015 Jan; 16(1):5137. PubMed ID: 25679172
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Focal boost to residual gross tumor volume in brachytherapy for cervical cancer-A feasibility study.
    Thiruthaneeswaran N; Groom N; Lowe G; Bryant L; Hoskin PJ
    Brachytherapy; 2018; 17(1):181-186. PubMed ID: 29153466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.